Additionally, experiments in mice show that NGF antibody treatment reduces bone damage caused by tumors, delays fracture time, and prolongs the use of tumor-carrying limbs, although the underlying mechanisms of these effects are unknown (32). The gene discussed is NGF; the disease is neoplasm.